Prescription copay reduction program for diabetic employees: Impact on medication compliance and healthcare costs and utilization

American Health and Drug Benefits

Volumn 2, Issue 1, 2009, Pages 14-24

  Nair, Kavita V ^a,e   Miller, Kerri ^b   Saseen, Joseph ^c,f   Wolfe, Pamela ^c   Allen, Richard Read ^c   Park, Jinhee ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b Pharmacy Services   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d GLAXOSMITHKLINE   (United States)

^e CENTOCOR INC   (United States)

^f DAIICHI SANKYO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GENERIC DRUG; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG COST; DRUG UTILIZATION; EMPLOYEE ATTITUDE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; SEX DIFFERENCE;

EID: 77953375036     PISSN: 19422962     EISSN: 19422970     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hunt S, Maerki S, Rosenberg W. Assessing quality-based benefit design. April 2006. www.chcf.org/documents/insurance/ QualityBasedBenefitDesignFullReport.pdf. Accessed November 25, 2008.
2. National Business Coalition on Health. Enhancing the evidence links in eValue8 value based benefit design content description. November 2007.www.evalue8.org/eValue8/about/evidencebriefing_vbbd.pdf. Accessed November 25, 2008.
3. Fendrick AM, Chemew ME. Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. Am J Manag Care. 2006;12(Spec No):SP5-SP10.
4. CCH HR Management. Employers shifting towards value-based benefit design, survey shows. May 19, 2008. http://hr.cch.com/news/hrm/ 051908a.asp. Accesed November 5, 2008.
5. Health Industries Research Companies. Employer & Coalition Services: value-based benefits designs. Fall 2007. http://hirc.com/files/public/ HIRC_ValueBasedBenefits.pdf. Accessed November 25, 2008.
6. Chernew M, Fendrick AM. Value and increased cost sharing in the American health care system. Health Serv Res. 2008;43:451-457.
7. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-429.
8. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43:173-184.
9. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005;11(5 suppl):S170-S176.
10. Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008;27:103-112.
11. Denny CC, Emanuel EJ, Pearson SD. Why well-insured patients should demand value-based insurance benefits. JAMA. 2007;297:2515-2518.
12. Conway C. MBGH annual employer benefit survey reveals growing shift to value-based benefit design. May 1, 2008. www.reuters.com/article/ pressRelease/idUS127367+01-May-2008+PRN 20080501. Accessed November 5, 2008.
13. Research Data Assistance Center (ResDAC) at the University of Minnesota, School of Public Health, Division of Health Services Research & Policy. Chronic condition data warehouse. October 2008. www.resdac.unm.edu/CCW/data_available.asp. Accessed December 6, 2008.
14. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalizations and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-1841.
15. Robst J, Levy JM, Ingber MJ. Diagnosis-based risk adjustment for Medicare prescription drug plan payments. Health Care Financ Rev. 2007;28:15-30.
16. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
17. Express Scripts. 2006 Drug Trend Report. April 2007. www.express-scripts.com/industryresearch/industryreports[drugtrendreport/ 2006/dtrFinal.pdf. Accessed November 5, 2008.
18. Express Scripts. 2007 Drug Trend Report. April 2008. www.express-scripts.com/industryresearch/industryreports/drugtrendreport/ 2007/dtrFinal.pdf. Accessed November 5, 2008.
19. Morrison, K. Wal-Mart expands low-price drug program. May 7, 2008. Business. The Morning News. www.nwaonline.net/articles/2008/05/05/ business/050608bizwmdrugs.txt. Accessed November 5, 2008.